YGF-31361-30183
4 vaccinations
3 coded responses
50 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 921 / CA
- Registered
- 2021-04-23
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-23
Registered in v-safe
-
2021-04-23
Dose 1 — Pfizer-BioNTech
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-05-02
- 2021-05-07
-
2021-05-14
Dose 2 — Pfizer-BioNTech
-
2021-05-14
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tirednessAdult check-in
-
2021-05-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-05-16
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-17
- 2021-05-18
- 2021-05-19
- 2021-05-20
- 2021-05-22
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
- 2021-06-25
- 2021-08-13
- 2021-11-14
-
2021-12-23
Dose 3 — Moderna
-
2021-12-25
Survey response — days 1–6 daily, dose 3MedDRA: Fatigue, Pain, Pain in jaw, Pain of skin, Pruritus, Sensitive skin, Urticaria — Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Rash, not including the immediate area around the injection siteFree text: Hives-like itching on hands and later feet/ankles, elbows, hips; achy/sensitive scalp; day 1 had full body ache with strong concentration around jaw & scalp, severe fatigue, and skin sensitivity (normal clothes and bedding felt unbearably scratchy)MedDRA releases: 2024-11 · check-in free text available
- 2021-12-26
- 2021-12-27
- 2021-12-28
- 2021-12-29
- 2021-12-30
- 2022-01-06
- 2022-01-13
- 2022-01-20
- 2022-01-27
- 2022-02-03
- 2022-03-24
- 2022-06-23
-
2022-10-01
Dose 4 — Moderna
-
2022-10-02
Survey response — days 1–6 daily, dose 4MedDRA: Pain of skin, Sensitive skin — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to do your normal daily activitiesFree text: Sensitive/achy skin & scalpMedDRA releases: 2024-11 · check-in free text available
- 2022-10-03
- 2022-10-04
- 2022-10-05
- 2022-10-07
- 2022-10-08
- 2022-10-15
- 2022-10-22
- 2022-10-29
- 2022-11-05
- 2022-11-12
-
2022-12-31
Survey response — 3 months, dose 4MedDRA: Cough, Nasal disorder, Nasopharyngitis, SARS-CoV-2 test negative, Secretion discharge, Sinus disorder, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: 3 week long winter cold, primary presentation in sinus & nasal passages, some mucous transitioned to a cough via post-nasal drip. Tested negative with home covid-19 antigen tests ~5 times.MedDRA releases: 2024-11 · check-in free text available
- 2023-04-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-23 | Pfizer-BioNTech | |
| 2 | 2021-05-14 | Pfizer-BioNTech | |
| 3 | 2021-12-23 | Moderna | No |
| 4 | 2022-10-01 | Moderna | No |
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Hives-like itching on hands and later feet/ankles, elbows, hips; achy/sensitive scalp; day 1 had full body ache with strong concentration around jaw & scalp, severe fatigue, and skin sensitivity (normal clothes and bedding felt unbearably scratchy) cut off by CDC
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Sensitive/achy skin & scalp
Release 12 — 3 months, dose 4
Symptoms: 3 week long winter cold, primary presentation in sinus & nasal passages, some mucous transitioned to a cough via post-nasal drip. Tested negative with home covid-19 antigen tests ~5 times.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Nasal disorder | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
| SD | Upper-airway cough syndrome | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Pain | · | · | ✓ |
| SRO | Pain in jaw | · | · | ✓ |
| SRO | Pain of skin | · | · | ✓ |
| SRO | Pruritus | · | · | ✓ |
| SRO | Sensitive skin | · | · | ✓ |
| SRO | Urticaria | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release